Ontology highlight
ABSTRACT: Background
Twenty percent to 40% of infants exposed to in utero opioid were delivered preterm. There is currently no neonatal abstinence syndrome (NAS) scoring tool known to accurately evaluate preterm opioid-exposed infants. This can lead to difficulties in titrating pharmacotherapy in this population.Purpose
To describe NAS symptoms in preterm opioid-exposed infants in comparison with matched full-term controls.Methods
This was a retrospective cohort study from a single tertiary care center of methadone-exposed infants born between 2006 and 2010. Using modified Finnegan scale scores recorded every 3 to 4 hours beginning at 6 hours of life until 24 to 48 hours after medication discontinuation, NAS symptoms was compared between 45 preterm infants and 49 full-term ma
SUBMITTER: Allocco E
PROVIDER: S-EPMC5042827 | biostudies-literature | 2016 Oct
REPOSITORIES: biostudies-literature